Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.

Bergmark, Bohula, Marston, Park, Kuder, Murphy, Ferrari, D., Leiter, Nicolau, Averkov, Charng, Ebenbichler, Erglis, Gouni-Berthold, Montalescot, Nicholls, Sigurdsson, Sinnaeve, Slapikas, . . . Sabatine (2026). Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.. Circulation.

Bergmark, Bohula, Marston, Park, Kuder, Murphy, et al. Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.. Circulation. 2026; PMID: 42153665

Bergmark, Bohula, Marston, et al. Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.[J]. Circulation. 2026.

@article{bergmark2026,
  author = {Bergmark and Bohula and Marston and Park and Kuder and Murphy and De Ferrari and Leiter and Nicolau and Averkov and Charng and Ebenbichler and Erglis and Gouni-Berthold and Montalescot and Nicholls and Sigurdsson and Sinnaeve and Slapikas and Tsioufis and Verma and Viigimaa and Bhatia and Xin and Walsh and Ohman and Giugliano and Sabatine},
  title = {Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.},
  journal = {Circulation},
  year = {2026},
  note = {PMID: 42153665},
}

TY  - JOUR
AU  - Bergmark
AU  - Bohula
AU  - Marston
AU  - Park
AU  - Kuder
AU  - Murphy
AU  - De Ferrari
AU  - Leiter
AU  - Nicolau
AU  - Averkov
AU  - Charng
AU  - Ebenbichler
AU  - Erglis
AU  - Gouni-Berthold
AU  - Montalescot
AU  - Nicholls
AU  - Sigurdsson
AU  - Sinnaeve
AU  - Slapikas
AU  - Tsioufis
AU  - Verma
AU  - Viigimaa
AU  - Bhatia
AU  - Xin
AU  - Walsh
AU  - Ohman
AU  - Giugliano
AU  - Sabatine
TI  - Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior MI: Results From the VESALIUS-CV Trial.
T2  - Circulation
PY  - 2026
AN  - PMID:42153665
ER  -